|
1
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33.
2022.PubMed/NCBI
|
|
2
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
3
|
Pullella K and Kotsopoulos J: Arsenic
exposure and breast cancer risk: A Re-evaluation of the literature.
Nutrients. 12:33052020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rosenberg AJ, Agrawal N, Pearson A, Gooi
Z, Blair E, Cursio J, Juloori A, Ginat D, Howard A, Chin J, et al:
Risk and response adapted de-intensified treatment for
HPV-associated oropharyngeal cancer: Optima paradigm expanded
experience. Oral Oncol. 122:1055662021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park S, Ahn S, Kim DG, Kim H, Kang SY and
Kim KM: High frequency of juxtamembrane domain ERBB2 mutation in
gastric cancer. Cancer Genomics Proteomics. 19:105–112. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tseng CM, Chen YT, Tao CW, Ou SM, Hsiao
YH, Li SY, Chen TJ, Perng DW and Chou KT: Adult narcoleptic
patients have increased risk of cancer: A nationwide
population-based study. Cancer Epidemiol. 39:793–797. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hrdlickova B, de Almeida RC, Borek Z and
Withoff S: Genetic variation in the non-coding genome: Involvement
of micro-RNAs and long non-coding RNAs in disease. Biochim Biophys
Acta. 1842:1910–1922. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou Y, Zhang X and Klibanski A: MEG3
noncoding RNA: A tumor suppressor. J Mol Endocrinol. 48:R45–R53.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schuster-Gossler K, Bilinski P, Sado T,
Ferguson-Smith A and Gossler A: The mouse Gtl2 gene is
differentially expressed during embryonic development, encodes
multiple alternatively spliced transcripts, and may act as an RNA.
Dev Dyn. 212:214–228. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miyoshi N, Wagatsuma H, Wakana S,
Shiroishi T, Nomura M, Aisaka K, Kohda T, Surani MA, Kaneko-Ishino
T and Ishino F: Identification of an imprinted gene, Meg3/Gtl2 and
its human homologue MEG3, first mapped on mouse distal chromosome
12 and human chromosome 14q. Genes Cells. 5:211–220. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ahmadi A, Rezaei A, Khalaj-Kondori M and
Khajehdehi M: A comprehensive bioinformatic analysis identifies a
tumor suppressor landscape of the MEG3 lncRNA in breast cancer.
Indian J Surg Oncol. 15:752–761. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Coan M, Haefliger S, Ounzain S and Johnson
R: Targeting and engineering long non-coding RNAs for cancer
therapy. Nat Rev Genet. 25:578–595. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu SJ, Dang HX, Lim DA, Feng FY and Maher
CA: Long noncoding RNAs in cancer metastasis. Nat Rev Cancer.
21:446–460. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu J, Liu S, Ye F, Shen Y, Tie Y, Zhu J,
Wei L, Jin Y, Fu H, Wu Y and Zheng X: Long Noncoding RNA MEG3
interacts with p53 protein and regulates partial p53 target genes
in hepatoma cells. PLoS One. 10:e01397902015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
He C, Wang X, Luo J, Ma Y and Yang Z: Long
noncoding RNA maternally expressed gene 3 is downregulated, and its
insufficiency correlates with Poor-risk stratification, worse
treatment response, as well as unfavorable survival data in
patients with acute myeloid leukemia. Technol Cancer Res Treat.
19:15330338209458152020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Buttarelli M, De Donato M, Raspaglio G,
Babini G, Ciucci A, Martinelli E, Baccaro P, Pasciuto T, Fagotti A,
Scambia G and Gallo D: Clinical value of lncRNA MEG3 in High-grade
serous ovarian cancer. Cancers (Basel). 12:9662020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ji Y, Feng G, Hou Y, Yu Y, Wang R and Yuan
H: Long noncoding RNA MEG3 decreases the growth of head and neck
squamous cell carcinoma by regulating the expression of miR-421 and
E-cadherin. Cancer Med. 9:3954–3963. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cao X, Zhuang S, Hu Y, Xi L, Deng L, Sheng
H and Shen W: Associations between polymorphisms of long non-coding
RNA MEG3 and risk of colorectal cancer in Chinese. Oncotarget.
7:19054–19059. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhuo ZJ, Zhang R, Zhang J, Zhu J, Yang T,
Zou Y, He J and Xia H: Associations between lncRNA MEG3
polymorphisms and neuroblastoma risk in Chinese children. Aging
(Albany NY). 10:481–491. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang Z, Li H, Li J, Lv X, Gao M, Bi Y,
Zhang Z, Wang S, Li S, Li N, et al: Association between long
noncoding RNA MEG3 polymorphisms and lung cancer susceptibility in
Chinese northeast population. DNA Cell Biol. 37:812–820. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Moher D, Liberati A, Tetzlaff J and Altman
DG: Preferred reporting items for systematic reviews and
meta-analyses: The PRISMA statement. J Clin Epidemiol.
62:1006–1012. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stang A: Critical evaluation of the
Newcastle-Ottawa scale for the assessment of the quality of
nonrandomized studies in Meta-analyses. Eur J Epidemiol.
25:603–605. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huedo-Medina TB, Sánchez-Meca J,
Marín-Martínez F and Botella J: Assessing heterogeneity in
meta-analysis: Q statistic or I2 index? Psychol Methods.
11:193–206. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
DerSimonian R: Meta-analysis in the design
and monitoring of clinical trials. Stat Med. 15:1237–1252. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mantel N and Haenszel W: Statistical
aspects of the analysis of data from retrospective studies of
disease. J Natl Cancer Inst. 22:719–748. 1959.PubMed/NCBI
|
|
26
|
Egger M, Davey Smith G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Q, Ai L and Dai Y: Association
between polymorphism of long non-coding RNA maternally expressed
gene 3 and risk of gastric cancer. Chin J Bases Clin Gen Surg.
25:1323–1326. 2018.
|
|
28
|
Wei Z: Analysis of the Effect of Genetic
Variants of MEG3-P53-MDM2-PTEN Molecular Pathway on
Hepatocarcinogenesis. Master's degree dissertation. 2019.
|
|
29
|
Ali MA, Shaker OG, Alazrak M, AbdelHafez
MN, Khalefa AA, Hemeda NF, Abdelmoktader A and Ahmed FA:
Association analyses of a genetic variant in long non-coding RNA
MEG3 with breast cancer susceptibility and serum MEG3 expression
level in the Egyptian population. Cancer Biomark. 28:49–63. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zheng Y, Wang M, Wang S, Xu P, Deng Y, Lin
S, Li N, Liu K, Zhu Y, Zhai Z, et al: LncRNA MEG3 rs3087918 was
associated with a decreased breast cancer risk in a Chinese
population: A case-control study. BMC Cancer. 20:6592020.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu B, Zhang M, Liu C, Wang C, You Z, Wang
Y and Chen M: Association of Long Non-coding RNA MEG3 polymorphisms
and risk of prostate cancer in chinese han population. Urol J.
18:176–180. 2020.PubMed/NCBI
|
|
32
|
Kong X, Yang S, Liu C, Tang H, Chen Y,
Zhang X, Zhou Y and Liang G: Relationship between MEG3 gene
polymorphism and risk of gastric cancer in Chinese population with
high incidence of gastric cancer. Biosci Rep. 40:BSR202003052020.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mazraeh SA, Gharesouran J, Ghafouri-Fard
S, Ganjineh Ketab FN, Hosseinzadeh H, Moradi M, Javadlar M,
Hiradfar A, Rezamand A, Taheri M and Rezazadeh M: Association
between WT1 and MEG3 polymorphisms and risk of acute myeloid
leukemia. Meta Gene. 23:1006362020. View Article : Google Scholar
|
|
34
|
Wang XR: Association analyses of genetic
variants in long non-coding RNA MEG3 with diffuse large B-cell
lymphoma susceptibility in Chinese Han population. Master's degree
dissertation. 2020.
|
|
35
|
Gao X, Li X, Zhang S and Wang X: The
association of MEG3 gene rs7158663 polymorphism with cancer
susceptibility. Front Oncol. 11:7967742021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shaker O, Ayeldeen G and Abdelhamid A: The
impact of single nucleotide polymorphism in the Long Non-coding
MEG3 gene on MicroRNA-182 and MicroRNA-29 expression levels in the
development of breast cancer in egyptian women. Front Genet.
12:6838092021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mohammed SR, Shaker OG, Mohamed MM,
Abdelhafez Mostafa MN, Gaber SN, Ali DY, Hussein HA, Elebiary AM,
Abonar AA, Eid HM and El Sayed Ali HS: The emerging role of lncRNA
MEG3 and MEG3 rs7158663 in hepatocellular carcinoma. Eur Rev Med
Pharmacol Sci. 26:11–21. 2022.PubMed/NCBI
|
|
38
|
Pei JS, Chang WS, Chen CC, Mong MC, Hsu
SW, Hsu PC, Hsu YN, Wang YC, Tsai CW and Bau DT: Novel Contribution
of Long Non-coding RNA MEG3 genotype to prediction of childhood
leukemia risk. Cancer Genomics Proteomics. 19:27–34. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hou Y, Zhang B, Miao L, Ji Y, Yu Y, Zhu L,
Ma H and Yuan H: Association of long non-coding RNA MEG3
polymorphisms with oral squamous cell carcinoma risk. Oral Dis.
25:1318–1324. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jeong YH and Zhao ZH: Correlation between
long noncoding RNA Meg3 polymorphism and risk of oral squamous cell
carcinoma. J Modern Stomatol. 33:328–332. 2019.(In Chinese).
|
|
41
|
Mirzazadeh S, Sarani H, Nakhaee A, Hashemi
SM, Taheri M, Hashemi M and Bahari G: Association between PAX8AS1
(rs4848320 C > T, rs1110839 G > T, and rs6726151 T > G)
and MEG3 (rs7158663) gene polymorphisms and non-Hodgkin lymphoma
risk. Nucleosides Nucleotides Nucleic Acids. 41:1174–1186. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang CT, Wu HY, Xia W, Cheng YP, Yang S,
Feng YL, Lu XY, Liang GY and Xu M: The association between
polymorphisms in long non-coding RNA MEG3 and the different
cervical lesions. Modern Oncol. 30:2804–2810. 2022.(In
Chinese).
|
|
43
|
Elhelaly Elsherbeny M, Ramadan Elsergany A
and Gamil Shaker O: Association of lncRNA MEG3 Rs7158663
polymorphism and serum expression with colorectal cancer in
egyptian patients. Rep Biochem Mol Biol. 12:102–111.
2023.PubMed/NCBI
|
|
44
|
Asadi A, Barati F, Nakhaee A, Jahantigh D,
Hashemi SM, Taheri M and Bahari G: Association between PRNCR1,
PAX8AS1, MEG3, and PTENP1 gene polymorphisms and breast cancer
risk. Per Med. 21:373–383. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang Y, Gao F and Lu J: MEG3 rs7158663
genetic polymorphism is associated with the risk of hepatocellular
carcinoma. Nucleosides Nucleotides Nucleic Acids. 44:531–541. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lao X, Wang Y, Huang R, He Y, Lu H and
Liang D: Genetic variants of LncRNAs HOTTIP and MEG3 influence
nasopharyngeal carcinoma susceptibility and clinicopathologic
characteristics in the Southern Chinese population. Infect Agent
Cancer. 19:322024. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Abdi E, Latifi-Navid S, Kholghi-Oskooei V,
Mostafaiy B, Pourfarzi F and Yazdanbod A: Roles of the lncRNAs
MEG3, PVT1 and H19 tagSNPs in gastric cancer susceptibility. BMC
Cancer. 24:14402024. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cao W, Chen HD, Yu YW, Li N and Chen WQ:
Changing profiles of cancer burden worldwide and in China: A
secondary analysis of the global cancer statistics 2020. Chin Med J
(Engl). 134:783–791. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global Cancer Statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 Countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI
|
|
50
|
Mattick JS, Amaral PP, Carninci P,
Carpenter S, Chang HY, Chen LL, Chen R, Dean C, Dinger ME,
Fitzgerald KA, et al: Long non-coding RNAs: Definitions, functions,
challenges and recommendations. Nat Rev Mol Cell Biol. 24:430–447.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Bridges MC, Daulagala AC and Kourtidis A:
LNCcation: LncRNA localization and function. J Cell Biol.
220:e2020090452021. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Nandwani A, Rathore S and Datta M: LncRNAs
in cancer: Regulatory and therapeutic implications. Cancer Lett.
501:162–171. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ma L, Bajic VB and Zhang Z: On the
classification of long non-coding RNAs. RNA Biol. 10:925–933. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ahmad M, Weiswald LB, Poulain L, Denoyelle
C and Meryet-Figuiere M: Involvement of lncRNAs in cancer cells
migration, invasion and metastasis: Cytoskeleton and ECM crosstalk.
J Exp Clin Cancer Res. 42:1732023. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ahadi A: Functional roles of lncRNAs in
the pathogenesis and progression of cancer. Genes Dis. 8:424–437.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
He Y, Luo Y, Liang B, Ye L, Lu G and He W:
Potential applications of MEG3 in cancer diagnosis and prognosis.
Oncotarget. 8:73282–73295. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhang J, Lin Z, Gao Y and Yao T:
Downregulation of long noncoding RNA MEG3 is associated with poor
prognosis and promoter hypermethylation in cervical cancer. J Exp
Clin Cancer Res. 36:52017. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Statello L, Guo CJ, Chen LL and Huarte M:
Gene regulation by long non-coding RNAs and its biological
functions. Nat Rev Mol Cell Biol. 22:96–118. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ghaedi H, Zare A, Omrani MD, Doustimotlagh
AH, Meshkani R, Alipoor S and Alipoor B: Genetic variants in long
noncoding RNA H19 and MEG3 confer risk of type 2 diabetes in an
Iranian population. Gene. 675:265–271. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Virolainen SJ, VonHandorf A, Viel K,
Weirauch MT and Kottyan LC: Gene-environment interactions and their
impact on human health. Genes Immun. 24:1–11. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Su H and Xie H: Associations between
lifestyle habits, environmental factors and respiratory diseases: A
cross-sectional study from southwest China. Front Public Health.
13:15139262025. View Article : Google Scholar : PubMed/NCBI
|
